Litcius/Paper detail

Parkinson’s disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM

Kun Zhao, Yeh‐Jun Lim, Zhenying Liu, Houfang Long, Yunpeng Sun, Jin‐Jian Hu, Chunyu Zhao, Youqi Tao, Xing Zhang, Dan Li, Yanmei Li, Cong Liu

2020Proceedings of the National Academy of Sciences202 citationsDOIOpen Access PDF

Abstract

Posttranslational modifications (PTMs) of α-synuclein (α-syn), e.g., phosphorylation, play an important role in modulating α-syn pathology in Parkinson's disease (PD) and α-synucleinopathies. Accumulation of phosphorylated α-syn fibrils in Lewy bodies and Lewy neurites is the histological hallmark of these diseases. However, it is unclear how phosphorylation relates to α-syn pathology. Here, by combining chemical synthesis and bacterial expression, we obtained homogeneous α-syn fibrils with site-specific phosphorylation at Y39, which exhibits enhanced neuronal pathology in rat primary cortical neurons. We determined the cryo-electron microscopy (cryo-EM) structure of the pY39 α-syn fibril, which reveals a fold of α-syn with pY39 in the center of the fibril core forming an electrostatic interaction network with eight charged residues in the N-terminal region of α-syn. This structure composed of residues 1 to 100 represents the largest α-syn fibril core determined so far. This work provides structural understanding on the pathology of the pY39 α-syn fibril and highlights the importance of PTMs in defining the polymorphism and pathology of amyloid fibrils in neurodegenerative diseases.

Topics & Concepts

FibrilPhosphorylationNeuropathologyAlpha-synucleinChemistryAmyloid (mycology)Amyloid fibrilParkinson's diseaseNeuroscienceCell biologyBiophysicsBiochemistryBiologyAmyloid βDiseasePathologyMedicineInorganic chemistryParkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsGenetic Neurodegenerative Diseases